Precision Oncology at Scale: Lantern Pharma’s Strategic Vision with CEO Panna Sharma

Small Stocks, Big Money ›

17:58 | Jul 29th

Lantern Pharma Inc. (Nasdaq: LTRN) is a clinical-stage biopharmaceutical company redefining oncology drug development through artificial intelligence. Its proprietary RADR® platform leverages over 200...Show More